THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

Translational Genomics Research Institute specializes in advanced biomedical research and genomic analysis, with deep expertise in proteome-wide epitope discovery, host transcriptome profiling, and long-read RNA sequencing. The organization conducts cutting-edge studies on infectious disease mechanisms, particularly tuberculosis, leveraging high-throughput genomic technologies to map host-pathogen interactions and identify immune response signatures. Their work integrates multi-omics approaches to investigate the developmental origins of disease, with a strong focus on sex-based biological differences and their impact on immune outcomes. Technical capabilities include high-resolution molecular phenotyping, computational immunology, and clinical-grade sequencing platform operations, positioning them as a specialized research partner for complex infectious disease and translational immunology challenges. The contractor maintains a consistent relationship with the Department of Health and Human Services, delivering high-complexity genomic and proteomic research services under targeted funding initiatives. They also engage with the National Institutes of Health, specifically the NHGRI, on studies exploring the biological underpinnings of disease susceptibility and immune response heterogeneity. Their work for these agencies centers on hypothesis-driven, data-intensive life science research requiring rigorous experimental design and analytical rigor. Their primary NAICS classification, 541714, reflects their core mission in biotechnology research—specifically, the application of genomic and molecular tools to understand human disease mechanisms without reliance on nanobiotechnology. Complementary work under 621511 demonstrates operational capacity in clinical-grade medical laboratory services, particularly in RNA sequencing and molecular diagnostics. This dual focus on discovery science and service delivery enables a unique bridge between basic research and translational application. As a non-certified entity based in Phoenix, Arizona, Translational Genomics Research Institute operates as an independent research organization with a focused presence in the federal life sciences market. Their value lies in specialized technical execution rather than broad compliance certifications, serving as a niche provider for agencies requiring advanced genomic and immunological research capabilities.